Big Gain For Immunovant, Inc.
Fri, Aug 19, 2022 at 06:58 PM
Immunovant, Inc. (IMVT:NASDAQ) jumped higher at $6.21, representing a gain of 21.1%. On Fri, Aug 19, 2022, IMVT:NASDAQ hit a New 2-Week High of $6.21. The stock appeared on our News Catalysts scanner on Thu, Aug 18, 2022 at 12:44 PM in the 'BIOTECH' category. From Fri, Aug 05, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Thu, Mar 17, 2022 at $6.59 with a volume of 1M+.
About Immunovant, Inc. (IMVT:NASDAQ)
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
Top 10 Gainers:
- GigaCloud Technology Inc (GCT:NASDAQ), 205.99%
- Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ), 80.23%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 40.35%
- Lottery.com Inc. (LTRY:NASDAQ), 31.83%
- Volcon Inc. (VLCN:NASDAQ), 31.52%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 29.54%
- Graphex Group Limited American Depositary Shares each American Depositary Share representing 20 (GRFX:NYSEMKT), 21.36%
- Immunovant, Inc. (IMVT:NASDAQ), 21.05%
- Foot Locker, Inc. (FL:NYSE), 20.04%